MEDTRONIC'S ITREL II FOR URGE INCONTINENCE SHOWS 79% SUCCESS RATE AT ONE YEAR; PANEL UNANIMOUSLY URGES APPROVAL CONTINGENT UPON ON POSTMARKET STUDY

More from Archive

More from Medtech Insight